Siyabonga ngokuvakashela i-Nature.com. Inguqulo yesiphequluli oyisebenzisayo inosekelo olulinganiselwe lwe-CSS. Ukuze uthole ulwazi olungcono kakhulu, sincoma ukuthi usebenzise isiphequluli esibuyekeziwe (noma ukhubaze i-Compatibility Mode ku-Internet Explorer). Okwamanje, ukuze siqinisekise ukwesekwa okuqhubekayo, sizonikeza isayithi ngaphandle kwezitayela ne-JavaScript.
Ama-peptide namaprotheni asetshenziswa kakhulu ukwelapha izifo ezahlukahlukene, kepha ngokuvamile kufanele ajovwe futhi umphumela wawo uphila isikhashana. Lokhu kushiyeka kwezakhiwo zomdabu kungaqedwa ngosizo lobunjiniyela bamangqamuzana, kodwa lokhu kuwumsebenzi onzima. Amasu wobunjiniyela bamangqamuzana, ekuqaleni asetshenziswa ku-insulin futhi manje asetshenziswa ngempumelelo kuma-biopharmaceuticals amaningana, adinga ukukhishwa kwama-peptide namaprotheni ku-fatty acids. Izici ezithile kanye nendawo yama-fatty acids anamathiselwe zinganikeza izindlela ezihlukene zokwelula. Ukwengeza, lobu buchwepheshe bungase bunikeze isigamu sempilo ende ngemva kokuphathwa ngomlomo kwezidakamizwa ze-peptide, zingashintsha ukusatshalaliswa kwama-peptide, futhi zingase zibe namandla okukhomba izicubu. Ngokuphepha okungokwemvelo kwama-acids anamafutha kanye nezakhiwo zamakhemikhali ezichazwe kahle, lobu buchwepheshe buhlinzeka ngendlela eguquguqukayo yokutholwa kwezidakamizwa ze-peptide namaprotheni.
Zonke izintengo zizonke. I-VAT izongezwa kamuva ekuphumeni. Izibalo zentela zizokwenziwa ekuphumeni.
Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF Amathrendi ekutholweni kwezidakamizwa ze-peptide. Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF Amathrendi ekutholweni kwezidakamizwa ze-peptide.UMuttenthaler, M., King, GF, Adams, DJ no-Alevud, PF Amathrendi ekutholweni kwezidakamizwa ze-peptide. Muttenthaler, M., King, GF, Adams, DJ & Alewood, PF 多肽药物发现的趋势. Muttenthaler, M., King, GF, Adams, DJ & Alewood, PFUMuttenthaler, M., King, GF, Adams, DJ no-Alevud, PF Amathrendi ekutholweni kwezidakamizwa ze-peptide.Kuzwelonke Ukuvulwa komfundisi wezidakamizwa. 20, 309–325 (2021). Lokhu kubuyekezwa kugxile ezicini zamanje nezesikhathi esizayo zokutholwa kwezidakamizwa ze-peptide.
I-Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD Ukutholwa kwezidakamizwa zokulwa nokukhuluphala: intuthuko nezinselele. I-Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD Ukutholwa kwezidakamizwa zokulwa nokukhuluphala: intuthuko nezinselele.I-Müller, TD, Blucher, M., Chop, MH kanye ne-DiMarchi, i-RD yokutholwa kwezidakamizwa zokulwa nokukhuluphala: inqubekelaphambili nezinselele. Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RD 抗肥胖药物发现：进展和挑战。 Müller, TD, Blüher, M., Tschöp, MH & DiMarchi, RDI-Müller, TD, Blucher, M., Chop, MH kanye ne-DiMarchi, i-RD yokutholwa kwezidakamizwa zokulwa nokukhuluphala: inqubekelaphambili nezinselele.Kuzwelonke Ukuvulwa komfundisi wezidakamizwa. 21, 201–223 (2022). Lokhu kubuyekezwa kunikeza ukuqonda ngezinkinga zokukhuluphala, ikakhulukazi imiqondo emisha esekelwe kuma-peptides.
I-Strohl, amaprotheni e-WR Fusion ukuze andise uhhafu wempilo ye-biologics njengesu elingcono kakhulu le-biologics. I-Biopharmaceutics 29, 215–239 ​​(2015).
Evans, M. et al. Ukubambelela kanye nokuphikelela kwezidakamizwa ze-antidiabetic kanye nokuhlangana nemiphumela yomtholampilo nezomnotho ezigulini ezinesifo sikashukela sohlobo 2: ukubuyekezwa okuhlelekile kwezincwadi. ukukhuluphala kwesifo sikashukela. umzimba. 24, 377–390 (2022).
I-Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH Imibono yesiguli ngemithi yesifo sikashukela kanye ngeviki. I-Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH Imibono yesiguli ngemithi yesifo sikashukela kanye ngeviki.I-Polonsky WH, i-Fisher L., i-Hessler D., i-Brune D., kanye nombono wesiguli ongcono kakhulu we-JH A ngemithi yesifo sikashukela etholakala kanye ngeviki. Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JH 患者对每周一次的糖尿病药物的看法. Polonsky, WH, Fisher, L., Hessler, D., Bruhn, D. & Best, JHI-Polonsky WH, i-Fisher L., i-Hessler D., i-Brune D., kanye ne-Best JH Patient perception yemithi yesifo sikashukela kanye ngesonto.ukukhuluphala kwesifo sikashukela. umzimba. 13, 144–149 (2011).
Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis of palmitoyl derivatives of insulin and their biological activities. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis of palmitoyl derivatives of insulin and their biological activities.I-Hashimoto M., Takada K., Kiso Y. kanye ne-Muranishi S. Synthesis yokuphuma kokuphuma kwe-palmitoyl kwe-insulin nomsebenzi wabo webhayoloji. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. 胰岛素棕榈酰衍生物的合成及其生物活性. Hashimoto, M., Takada, K., Kiso, Y. & Muranishi, S. Synthesis kanye nomsebenzi webhayoloji we-insulin palmitoyl derivatives.Hashimoto M., Takada K., Kiso Y. kanye ne-Muranishi S. Synthesis kanye nomsebenzi webhayoloji wokuphuma kokuphuma kwe-insulin palmitoyl.indawo yokugcina imithi 6, 171–176 (1989).
Kurtzhals, P. et al. I-Albumin ebophezela ku-insulin enamafutha e-acid-acylated: ukubonakaliswa kokusebenzelana kwe-ligand-protein kanye nokuhlobana phakathi kokuhlangana okubophayo kanye nesikhathi sesenzo se-insulin ku-vivo. i-biochem. J. 312, 725–731 (1995). Lo msebenzi ungowokuqala ukukhombisa ukwanda kwesigamu sempilo ngenxa yokuboshwa kwe-albumin kuma-peptide atholakala ku-fatty acid.
I-Mejuch, T. & Waldmann, H. Ukuhlanganiswa kwamaprotheni ane-lipidated. I-Mejuch, T. & Waldmann, H. Ukuhlanganiswa kwamaprotheni ane-lipidated.U-Meyukh, T. no-Waldmann, H. Ukuhlanganiswa kwamaprotheni ane-lipidated. U-Mejuch, T. & Waldmann, H. 脂化蛋白质的合成. Mejuch, T. & Waldmann, H.U-Meyukh, T. no-Waldmann, H. Ukuhlanganiswa kwamaprotheni ane-lipidated.I-Bioconjugate. Amakhemikhali. 27, 1771–1783 (2016).
U-Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Ukwehla kwamaprotheni ekuboniseni amaseli nezifo: umsebenzi, ukulawulwa, namathuba okwelapha. U-Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Ukwehla kwamaprotheni ekuboniseni amaseli nezifo: umsebenzi, ukulawulwa, namathuba okwelapha.U-Chen B., u-Sun Y., u-Niu J., u-Jarugumilli GK kanye no-Wu X. Ukugcwala kwamaprotheni ekuboniseni amaseli nesifo: umsebenzi, ukulawulwa, namandla okwelapha. Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. 细胞信号和疾病中的蛋白质脂化：功能、调节和治疗机会。 U-Chen, B., Sun, Y., Niu, J., Jarugumilli, GK & Wu, X. Protein脂化 ekuboniseni amaseli kanye nesifo: umsebenzi, ukulawulwa kanye namathuba okwelapha.U-Chen B., u-Sun Y., u-Niu J., u-Jarugumilli GK kanye no-Wu X. Ukugcwala kwamaprotheni ekuboniseni amaseli nesifo: umsebenzi, ukulawulwa, namandla okwelapha.i-cytochemistry. biology 25, 817–831 (2018).
I-Richter, i-WF, i-Bhansali, i-SG & Morris, i-ME Izinqumo ze-Mechanistic zokumuncwa kwe-biotherapeutics kulandela ukuphathwa kwe-SC. I-Richter, i-WF, i-Bhansali, i-SG & Morris, i-ME Izinqumo ze-Mechanistic zokumuncwa kwe-biotherapeutics kulandela ukuphathwa kwe-SC.Richter, VF, Bhansali, SG kanye no-Morris, ME Izindlela ezinquma ukumuncwa kwama-biotherapeutic agents ngemva kokuphathwa kwe-subcutaneous. Richter, WF, Bhansali, SG & Morris, ME SC 给药后生物治疗药物吸收的机制决定因素. Richter, WF, Bhansali, SG & Morris, ME SC Richter, WF, Bhansali, SG & Morris, ME SC Механистические детерминанты абсорбции биотерапевтических препаратов после введения. I-Richter, i-WF, i-Bhansali, i-SG & Morris, i-ME SC Izinqumo ze-Mechanistic zokumuncwa kwezidakamizwa ze-biotherapeutic ngemva kokuphathwa.I-AAPS J. 14, 559–570 (2012).
Gradel, AKJ et al. Izinto ezithinta ukumuncwa kwe-insulin engaphansi kwesikhumba: imiphumela yokuhlukahluka. J. Diabetes Res. 2018, 1205121 (2018).
U-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Ukusabalalisa kanye ne-polymerization kunquma ukumuncwa kwe-insulin kusuka ezicutshini ezingaphansi kwesikhumba ezigulini ezinesifo sikashukela. U-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Ukusabalalisa kanye ne-polymerization kunquma ukumuncwa kwe-insulin kusuka ezicutshini ezingaphansi kwesikhumba ezigulini ezinesifo sikashukela. I-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Диффузия и полимеризация определяют абсорбцию инсулина из подкожной ткание пание песни. U-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Ukusabalalisa kanye ne-polymerization kunquma ukumuncwa kwe-insulin kusuka kuzicubu ezingaphansi kwezicubu ezigulini ezinesifo sikashukela. Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. 扩散和聚合决定了糖尿病患者皮下组织对胰岛純的散。 Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. I-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Диффузия и агрегация определяют абсорбцию инсулина подкожной тканью песни U-Hildebrandt, P., Sejrsen, P., Nielsen, SL, Birch, K. & Sestoft, L. Ukusabalalisa nokuhlanganisa kunquma ukumuncwa kwe-insulin engaphansi kwesikhumba ezigulini ezinesifo sikashukela.ukuskena. J. Klin. ilabhorethri. tshala imali. 45, 685–690 (1985).
I-Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. Imodeli yokumuncwa kinetics ye-insulin encibilikayo efakwe ngaphansi kwesikhumba. I-Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. Imodeli yokumuncwa kinetics ye-insulin encibilikayo efakwe ngaphansi kwesikhumba.UMosekilde E, Jensen KS, Binder S, Pramming S, noThorsteinsson B. Ukumodela i-kinetics yokumuncwa kwe-subcutaneous soluble insulin. Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B. 模拟皮下注射可溶性胰岛素的吸收动力学。 Mosekilde, E., Jensen, KS, Binder, C., Pramming, S. & Thorsteinsson, B.UMosekilde E, Jensen KS, Binder S, Pramming S, noThorsteinsson B. Ukumodela i-kinetics yokumuncwa kwe-insulin encibilikayo elawulwa ngaphansi kwesikhumba.J. Pharmacokinetics. i-biopharmacy. 17, 67–87 (1989).
Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Usayizi wengqamuzana ushintsha i-pharmacokinetics, i-biodistribution, kanye nokufakwa kwezinso kokulethwa kwezidakamizwa kwe-biopolymer elastin-like polypeptide. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Usayizi wengqamuzana ushintsha i-pharmacokinetics, i-biodistribution, kanye nokufakwa kwezinso kokulethwa kwezidakamizwa kwe-biopolymer elastin-like polypeptide. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III для доставки лекарственного средства. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Usayizi wengqamuzana ushintsha i-pharmacokinetics, i-biodistribution, kanye nokufakwa kwezinso kwe-biopolymeric elastin-like polypeptide yokulethwa kwezidakamizwa. Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III分子大小调节药物递送生物聚合物弹性蛋白樣多肽的药代动力学、生物分帄旺和肾肉。 Kuna, M., Mahdi, F., Chade, AR & Bidwell, GL III Molecule 大小名行电影送送biological polymer elastic elastic sample 多如乐的药代报学学, ukusatshalaliswa kwebhayoloji ne-鈥規气。Kuna, M., Mahdi, F., Chad, AR kanye ne-Bidwell, GL III. I-Pharmacokinetics, i-biodistribution kanye nokufakwa kwezinso kwe-biopolymeric elastin-like polypeptides modulating size of the molecule.Umbiko wesayensi 8, 7923 (2018).
Harris, JM, Martin, NE & Modi, M. Pegylation: inqubo yenoveli yokuguqula i-pharmacokinetics. Harris, JM, Martin, NE & Modi, M. Pegylation: inqubo yenoveli yokuguqula i-pharmacokinetics. U-Harris, JM, Martin, NE & Modi, M. Пегилирование: новый процесс модификации фармакокинетики. Harris, JM, Martin, NE & Modi, M. Pegylation: inqubo yenoveli yokuguqula i-pharmacokinetics. U-Harris, JM, Martin, NE & Modi, M. 聚乙二醇化：一种改变药代动力学的新方法。 U-Harris, JM, Martin, NE & Modi, M. 聚乙二感化: indlela entsha yokushintsha imithi. U-Harris, JM, Martin, NE & Modi, M. Пегилирование: новый подход к изменению фармакокинетики. Harris, JM, Martin, NE & Modi, M. Pegylation: indlela entsha yokushintsha i-pharmacokinetics.emtholampilo. I-Pharmacokinetics. 40, 539–551 (2001).
Elmerer, M. et al. Ukulinganiswa kwe-albumin ye-interstitial kumisipha yamathambo omuntu kanye nezicubu ze-adipose ngokugeleza okuvulekile kwe-microperfusion. Yebo. J. Physiology. uhlelo lwe-endocrine. umzimba. 278, E352-E356 (2000).
Nelson, J. et al. Ingxenye yempilo ende ye-albumin kubantu idinga i-C-terminus eqinile. ukuxhumana. isayensi yezinto eziphilayo. 3, 181 (2020).
Chowdhury, K. et al. I-Fc receptor (FcRn) ye-IgG ehlotshaniswa nenkimbinkimbi enkulu ye-histocompatibility ibopha i-albumin futhi andise ubude bayo bempilo. J. Exp. umuthi. 197, 315–322 (2003).
Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Exocytosis ye-IgG njengoba kulamulwa yi-receptor, i-FcRn: ukuhlaziywa ezingeni le-molecule eyodwa. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Exocytosis ye-IgG njengoba kulamulwa yi-receptor, i-FcRn: ukuhlaziywa ezingeni le-molecule eyodwa. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Экзоцитоз IgG, опосредованный рецептором FcRn: анализ на уровне одной молекулы. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES FcRn receptor-mediated IgG exocytosis: ukuhlaziywa kwe-molecule eyodwa. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES 受体介导的IgG 胞吐作用，FcRn：单分子水平的分析。 Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, Экзоцитоз IgG, опосредованный рецептором ES, FcRn: анализ на уровне одной молекулы. Ober, RJ, Martinez, C., Lai, X., Zhou, J. & Ward, ES receptor-mediated IgG exocytosis, FcRn: ukuhlaziywa kweleveli ye-molecule eyodwa.inqubo. I-National Academy of Science. isayensi. US 101, 11076 (2004).
Yena, i-XM & Carter, isakhiwo se-DC Atomic kanye nekhemikhali ye-albumin ye-serum yomuntu. Yena, i-XM & Carter, isakhiwo se-DC Atomic kanye nekhemikhali ye-albumin ye-serum yomuntu.Kuvuliwe, i-XM ne-Carter, i-DC Atomic structure kanye nekhemikhali ye-albumin ye-serum yomuntu. Yena, XM & Carter, DC 人血清白蛋白的原子结构和化学. Yena, i-XM & Carter, DC.Kuvuliwe, i-XM ne-Carter, i-DC Atomic structure kanye nekhemikhali ye-albumin ye-serum yomuntu.Imvelo 358, 209–215 (1992).
U-Curry, S., Mandelkow, H., Brick, P. & Franks, N. Isakhiwo se-Crystal se-albumin ye-serum yomuntu ehlanganiswe namafutha e-asidi sibonisa ukusatshalaliswa kwe-asymmetric kweziza ezibophayo. U-Curry, S., Mandelkow, H., Brick, P. & Franks, N. Isakhiwo se-Crystal se-albumin ye-serum yomuntu ehlanganiswe namafutha e-asidi sibonisa ukusatshalaliswa kwe-asymmetric kweziza ezibophayo.U-Curry S., u-Mandelkow H., uBrick P. no-Franks N. Isakhiwo sekristalu se-albumin ye-serum yomuntu eyinkimbinkimbi enamafutha anamafutha sibonisa ukusatshalaliswa kwe-asymmetric yezindawo ezibophayo. Curry, S., Mandelkow, H., Brick, P. & Franks, N. 与脂肪酸复合的人血清白蛋白的晶体结构揭示了结合位点的不 Curry, S., Mandelkow, H., Brick, P. & Franks, N. Isakhiwo sekristalu se-serum yephrotheni emhlophe yomuntu enama-acids anamafutha sibonisa ukusatshalaliswa kwe-asymmetric kweziza ezibophayo.U-Curry S., u-Mandelkow H., uBrick P. no-Franks N. Isakhiwo sekristalu se-albumin ye-serum yomuntu eyinkimbinkimbi enamafutha acid sibonisa ukusatshalaliswa kwe-asymmetric yezindawo ezibophezelayo.Nat. isakhiwo. biology 5, 827-835 (1998). Leli phepha lethula isisekelo sesakhiwo sokubopha ama-fatty acids ku-serum albumin.
I-Irby, D., Du, C. & Li, F. Lipid–drug conjugate ukuze kuthuthukiswe ukulethwa kwezidakamizwa. I-Irby, D., Du, C. & Li, F. Lipid–drug conjugate ukuze kuthuthukiswe ukulethwa kwezidakamizwa.I-Irby, D., Du, K. kanye ne-Li, F. I-Lipid-drug conjugates yokulethwa kwezidakamizwa okuthuthukisiwe. I-Irby, D., Du, C. & Li, F. Lipid-drug conjugate ukuze kuthuthukiswe ukulethwa kwezidakamizwa. I-Irby, D., Du, C. & Li, F. Lipid-drug conjugate ukuze kuthuthukiswe ukulethwa kwezidakamizwa.I-Irby, D., Du, K. kanye ne-Li, F. I-Lipid-drug conjugate yokulethwa kwezidakamizwa okuthuthukisiwe.I-Biochemistry 14, 1325–1338 (2017).
Torchilin VP Intuthuko yakamuva emkhakheni we-liposomes njengabathwali bezidakamizwa. Kuzwelonke Ukuvulwa komfundisi wezidakamizwa. 4, 145–160 (2005).
Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Amathuba nezinselelo ze-fatty acid conjugated therapeutics. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Amathuba nezinselelo ze-fatty acid conjugated therapeutics.I-Bhat, M., Jatyan, R., Mittal, A., Mahato, RI kanye ne-Chitkara, D. Amathuba nezinselelo ze-fatty acid conjugated therapeutics. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. 脂肪酸共轭疗法的机遇和挑战. I-Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Fatty acid 共续电影的机遇和challenge.Bhat M., Jatyan R., Mittal A., Mahato RI kanye ne-Chitkara D. Amathuba nezinselelo zokwelapha okuxutshwa kwe-fatty acid.Amakhemikhali. i-physics Lipids 236, 105053 (2021).
Smith, R. & Tanford, C. Hydrophobicity of long chain n-alkyl carboxylic acids, njengoba kukalwa ngokusatshalaliswa kwawo phakathi kwe-heptane nezixazululo ezinamanzi. Smith, R. & Tanford, C. Hydrophobicity of long chain n-alkyl carboxylic acids, njengoba kukalwa ngokusatshalaliswa kwawo phakathi kwe-heptane nezixazululo ezinamanzi.Smith, R. kanye ne-Tanford, K. I-Hydrophobicity ye-long-chain n-alkylcarboxylic acid elinganiswa ngokusatshalaliswa kwayo phakathi kwe-heptane ne-aqueous solutions. Smith, R. & Tanford, C. 长链正烷基羧酸的疏水性，通过它們在庚烷和水溶液之间的分布來测量. USmith, R. & Tanford, C. I-hydrophobicity ye-长链正alkylcarboxylate, kukalwa ngokusatshalaliswa kwayo phakathi kwe-hydrogen peroxide nesisombululo esinamanzi.Smith, R. kanye ne-Tanford, K. I-Hydrophobicity ye-long-chain n-alkylcarboxylic acid elinganiswa ngokusatshalaliswa kwayo phakathi kwe-heptane ne-aqueous solutions.inqubo. I-National Academy of Sciences. isayensi US 70, 289 (1973).
U-Liu, J. et al. Ukutholwa kanye ngeviki kwe-semaglutide analog ye-glucagon-like peptide-1 (GLP-1). J. Imithi. Amakhemikhali. 58, 7370–7380 (2015). Lo msebenzi ubonisa okokuqala ukuthi kungenzeka ukusebenzisa kanye ngesonto izindlela zokuphuma kwe-fatty acid.
Østergaard, S. et al. Umthelela we-PYY3-36 yomuntu we-dibasic fatty acylation kumsebenzi we-mini-pig Y2 receptor kanye nengxenye yempilo. isayensi. Bika 11, 21179 (2021). Lesi sihloko sibonisa ukubaluleka kwesikhundla se-fatty acid, isixhumanisi kanye nokuzinza komgogodla ekuthuthukisweni kwama-analogue e-PYY esigamu sempilo ende.
Ensenat-Vaser, R. et al. Ukungena kwama-peptide ama-myristoylated kuwo wonke ulwelwesi lweseli kwabonwa ngokuqondile kusetshenziswa i-confocal fluorescence microscopy. I-IUBMB Life 54, 33–36 (2002).
Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl-based transport of peptides to cells living. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE Myristoyl-based transport of peptides to cells living.Nelson AR, Borland L, Allbritton NL. kanye nokuthuthwa kwe-Sims SE Peptide kumaseli aphilayo kusekelwe ku-myristoyl. Nelson, AR, Borland, L., Allbritton, NL & Sims, CE 基于肉豆蔻酰的肽转运到活细胞中。 Nelson, AR, Borland, L., Allbritton, NL & Sims, CE.Nelson, AR, Borland, L., Albritton, NL. kanye ne-Sims, KE Ukuthutha kwama-peptide asekelwe ku-myristoyl kumaseli aphilayo.I-Biochemistry 46, 14771-14781 (2007).
I-Kabanov, i-AV, i-Levashov, i-AV & Alakhov, i-VY Lipid ukuguqulwa kwamaprotheni kanye nokuthuthwa kwawo kwe-membrane. I-Kabanov, i-AV, i-Levashov, i-AV & Alakhov, i-VY Lipid ukuguqulwa kwamaprotheni kanye nokuthuthwa kwawo kwe-membrane.Kabanov AV, Levashov AV, Alakhov V.Yu. Ukuguqulwa kwe-lipid yamaprotheni kanye nokuthuthwa kwawo kwe-membrane. Kabanov, AV, Levashov, AV & Alakhov, VY 蛋白质的脂质修饰及其膜转运. Kabanov, AV, Levashov, AV & Alakhov, VYI-Kabanov AV, i-Levashov AV, i-Alakhov, ukuguqulwa kwe-Lipid yamaprotheni e-VY kanye nokuthutha kwawo ulwelwesi.ubunjiniyela bamaprotheni. Disemba Searl. 3, 39–42 (1989).
I-Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN Fatty acylation ithuthukisa ukufakwa ngaphakathi kwamaselula kanye nokusatshalaliswa kwe-cytosolic kwe-cystine-knot peptide. I-Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN Fatty acylation ithuthukisa ukufakwa ngaphakathi kwamaselula kanye nokusatshalaliswa kwe-cytosolic kwe-cystine-knot peptide.I-Gao, i-X., i-Mazier, i-AD, i-Byrd, i-R., i-Klumperman, i-J. ne-Hannoosh, i-RN Fatty acid acylation ithuthukisa ukufakwa ngaphakathi kwamaselula kanye nokusatshalaliswa kwe-cytosolic kwe-peptide nge-cystine loop. Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN 脂肪酰化增强了胱氨酸结肽的细胞内化和胞质分布。 Gao, X., Mazière, AD, Beard, R., Klumperman, J. & Hannoush, RN.I-Gao, i-X., i-Mazier, i-AD, i-Byrd, i-R., i-Klumperman, i-J. ne-Hannoosh, i-RN Fatty acylation ithuthukisa ukufakwa ngaphakathi kwamaselula kanye nokusatshalaliswa kwe-cytoplasmic kwama-cystine peptides.iScience 24, 103220 (2021).
Baker, EM et al. Ukuguqulwa kokwandisa impilo yesigamu kwe-YY3-36 peptide yokungenisa ngaphakathi kwe-receptor-mediated ngqo. Moore. umuthi. 16, 3665–3677 (2019).
Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meiler, J. & Beck-Sickinger, AG Isikhundla nobude bama-acids anamafutha kuthinta kakhulu iphethini yokukhetha i-receiver yama-analogues we-pancreas polypeptide. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meiler, J. & Beck-Sickinger, AG Isikhundla nobude bama-acids anamafutha kuthinta kakhulu iphethini yokukhetha i-receiver yama-analogues we-pancreas polypeptide.Kwenziwe, W., Bellmann-Sickert, K., Kaiser, A., Mailer, J. kanye no-Beck-Sickinger, AG Isikhundla nobude bama-acids anamafutha kuthonya kakhulu iphethini yokukhetha yama-receptors e-analog ye-pancreas polypeptide. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meil ​​er, J. & Beck-Sickinger, AG脂肪酸的位置和长度强烈影响人胰腺多肽类似物的受体选择性模式. Mäde, V., Bellmann-Sickert, K., Kaiser, A., Meil ​​er, J. & Beck-Sickinger, AGKwenziwe, W., Bellmann-Sickert, K., Kaiser, A., Mailer, J. no-Beck-Sickinger, AG Isikhundla nobude bama-fatty acids kuthonya kakhulu iphethini yokukhetha yama-receptors e-analog polypeptide yabantu.HimMedChem 9, 2463–2474 (2014).
Aleksopoulou, F. et al. I-lipid metabolite PrRP31 iyi-agonist yesikhathi eside esebenza kabili ye-GPR10 kanye ne-NPFF2 enemiphumela enamandla yokuncipha kwesisindo. isayensi. Bika 12, 1696 (2022). Lolu cwaningo lwe-methodological lugqamisa umehluko phakathi kwamaketanga aseceleni e-mono- ne-diacid.
Poulsen, K. et al. Ukuthuthukiswa okunengqondo kwama-agonists azinzile we-Y2 receptor peptide PYY3-36. umuthi. ithangi lokugcina. 38, 1369–1385 (2021).
Conde-Frieboes, K. et al. Ukuhlonzwa kanye nokuchazwa kwe-in vitro kanye ne-in vivo analogue ye-melanocortin 4 receptor (MC4-R) esebenza isikhathi eside futhi ekhethiwe (MC4-R) i-alpha-melanocyte-stimulating hormone (alpha-MSH). J. Imithi. Amakhemikhali. 55, 1969–1977 (2012).
Ramirez-Andersen, HS et al. Ama-analogue ama-hormone okukhula komuntu asebenza isikhathi eside aboshwe ku-albumin engeyona i-covalent. I-Bioconjugate. Amakhemikhali. 29, 3129–3143 (2018).
Madsen, K. et al. Ubudlelwano besakhiwo nomsebenzi kanye nokwelulwa kokuphuma kokunye okufana ne-glucagon okufana ne-peptide-1 okuthatha isikhathi eside: ukubaluleka kobude be-acid enamafutha, i-polarity, nevolumu. J. Imithi. Amakhemikhali. 50, 6126–6132 (2007).
Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Okuphuma ku-GLP-1 okuneacylated kabili. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Okuphuma ku-GLP-1 okuneacylated kabili. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Дважды ацилированные производные GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Okuphuma kokuphuma kabili kwe-acylated kwe-GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. 双酰化GLP-1 衍生物. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. 双酰化GLP-1 衍生物. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. Диацилированные производные GLP-1. Wieczorek, B., Spetzler, JC, Kruse, T., Linderoth, L. & Kofoed, J. I-Diacylated derivatives ye-GLP-1.I-US Patent WO2012/140117 (2012).
Omusha, P.-Yu. Linda. Ama-analogue e-GLP-1 anamandla, asebenza isikhathi eside adizayinelwe ukulethwa kwe-transdermal ngokusekelwe ku-microstructure. inqubo. I-National Academy of Science. isayensi. US 113, 4140–4145 (2016).
Royalty, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Uphenyo lokuphepha, ukubekezelelana, i-pharmacokinetics, kanye ne-pharmacodynamics yemithamo eyodwa neningi ye-analog ye-α-MSH esebenza isikhathi eside ekukhulupheleni okunempilo nokukhuluphala. izifundo. Royalty, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Uphenyo lokuphepha, ukubekezelelana, i-pharmacokinetics, kanye ne-pharmacodynamics yemithamo eyodwa neningi ye-analog ye-α-MSH esebenza isikhathi eside ekukhulupheleni okunempilo nokukhuluphala. izifundo.I-Royalty, JE, i-Konradsen, G., Eskerod, O., Wolf, BS kanye no-Hansen, BS Safety, ukubekezelelana, i-pharmacokinetics, kanye ne-pharmacodynamics isifundo semithamo eyodwa neningi ye-analog ye-α-MSG esebenza isikhathi eside ezifundweni ezinempilo ezikhuluphele futhi ezikhuluphele.版税, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS 单剂量和多剂量长效α-MSH类似物在健康超重和肥胖患者中的安全性、耐受性、药代动力学和药效学研究科目。版税, JE, Konradsen, G., Eskerod, O., Wulff, BS & Hansen, BS Umthamo owodwa kanye nomphumela omude wemithamo eminingi α-MSH全健康超重和肥胖可以中可以可以而受性、药代报学学和药效学研究科目。I-Royalty, JE, Konradsen, G., Eskerod, O., Wolf, BS ne-Hansen, BS Safety, ukubekezelelana, i-pharmacokinetics yemithamo eyodwa kanye nenqwaba yama-analogue e-alpha-MSG asebenza isikhathi eside ezifundweni ezinempilo ezikhuluphele nokukhuluphele. I-Kinetics kanye ne-pharmacodynamics.J. Clin. I-Pharmacodynamics. 54, 394–404 (2014).
U-Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel glucagon analogue. U-Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. Novel glucagon analogue.U-Lau, J., F., Kruse, T., Linderoth, L. no-Togersen, H. Ama-analogue amasha eglucagon. Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H. 新型胰高血糖素类似物。 U-Lau, J., F., Kruse, T., Linderoth, L. & Thøgersen, H.U-Lau, J., F., Cruz, T., Linderoth, L. no-Togersen, H. Ama-analogue amasha eglucagon.I-US Patent WO2011/117416 A1 (2011).
Ward, BP et al. I-Lipidation yama-peptide iqinisa izakhiwo ukuze kuthuthukiswe ukusebenza kwebhayoloji. Moore. umzimba. 2, 468–479 (2013). Lo msebenzi ubonisa indima yamaketanga aseceleni e-fatty acid ekunqumeni ukuzinza kwesakhiwo nokubophezela kwama-receptors ezidakamizwa ze-peptide.
Koskun T. et al. I-LY3298176, inoveli emibili ye-GIP kanye ne-GLP-1 receptor agonist yokwelashwa kohlobo lwesifo sikashukela sohlobo 2: kusukela ekutholakaleni kuya ebufakazini bomtholampilo bomqondo. Moore. umzimba. 18, 3-14 (2018). Leli phepha lethula idizayini ye-GLP-1/GIP co-agonist yokuqala etholakala kumafutha e-asidi yokuphatha kanye ngeviki emtholampilo.
Kjeldsen, TB et al. Ubunjiniyela bamamolekyuli be-icodec insulin, i-analogue yokuqala ye-insulin ye-acylated kanye ngesonto kubantu. J. Imithi. Amakhemikhali. 64, 8942–8950 (2021). Leli phepha lethula ukuthuthukiswa kokuqala kwe-fatty acid etholakala ku-insulin yokuphathwa kanye ngesonto.
van Witteloostein, SB et al. I-Neoglycolipids yama-peptide asebenza isikhathi eside: ama-analogue azihlanganisayo e-glucagon-like peptide 1 enezakhiwo ezibopha i-albumin namandla aphezulu e-vivo. Moore. umuthi. 14, 193–205 (2017).
I-Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. I-heptapeptide ene-acylated ibopha i-albumin ngokuhambisana okuphezulu nokusebenza njengoba ithegi ihlinzeka ngama-peptide asebenza isikhathi eside. I-Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. I-heptapeptide ene-acylated ibopha i-albumin ngokuhambisana okuphezulu nokusebenza njengoba ithegi ihlinzeka ngama-peptide asebenza isikhathi eside.I-Zorzi, A., Middendorp, SJ, Wilbs, J., Dale, K. kanye noHaynes, S. I-heptapeptide e-acylated ibopha i-albumin ngokuhambisana okuphezulu, futhi ukusetshenziswa kwayo njengelebula kunikeza i-peptide esebenza isikhathi eside. Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. 酰化七肽以高亲和力结合白蛋白，并作為标签提供长木。 Zorzi, A., Middendorp, SJ, Wilbs, J., Deyle, K. & Heinis, C. 鎄化七peptide以高亲和力设计白白约筒，使用于设计手机。I-Zorzi, A., Middendorp, SJ, Wilbs, J., Dale, K. kanye no-Haynes, S. Acylated heptapeptides ahlanganisa i-albumin ngokuhambisana okuphezulu futhi asebenza njengamalebula okulethwa kwe-peptide okuthatha isikhathi eside.Nat. ukuxhumana 8, 16092 (2017).